About
Revel Pharmaceuticals develops engineered enzymes designed to recognize and enzymatically reverse age-related molecular damage such as collagen crosslinks, glycation, and pathological accumulations, aiming to treat conditions like neurodegeneration, heart disease, arthritis, skin aging, and gout.
Explore Revel Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.